6.97
+0.08(+1.16%)
Currency In USD
| Previous Close | 6.89 |
| Open | 7.01 |
| Day High | 7.51 |
| Day Low | 6.57 |
| 52-Week High | 23.4 |
| 52-Week Low | 3.52 |
| Volume | 4.45M |
| Average Volume | 1.66M |
| Market Cap | 318.37M |
| PE | -6.06 |
| EPS | -1.15 |
| Moving Average 50 Days | 11.74 |
| Moving Average 200 Days | 12.4 |
| Change | 0.08 |
If you invested $1000 in Capricor Therapeutics, Inc. (CAPR) 10 years ago, it would be worth $105.61 as of May 09, 2025 at a share price of $6.97. Whereas If you bought $1000 worth of Capricor Therapeutics, Inc. (CAPR) shares 5 years ago, it would be worth $852.08 as of May 09, 2025 at a share price of $6.97.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Capricor Therapeutics to Present First Quarter 2025 Financial Results and Recent Corporate Update on May 13
GlobeNewswire Inc.
May 06, 2025 1:15 PM GMT
Company to Host Conference Call, May 13, 2025 at 4:30 p.m. ETSAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment o
Capricor Therapeutics Announces Completion of Mid-Cycle Review Meeting with FDA on Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
GlobeNewswire Inc.
May 05, 2025 12:00 PM GMT
-Company remains on track for PDUFA target action date of August 31, 2025- -Advisory committee meeting to be held in advance of target action date- SAN DIEGO, May 05, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology
Caprock Announces Comprehensive Exploration & Resource Expansion Plan for Its Destiny Project
Newsfile
Apr 16, 2025 12:30 PM GMT
Toronto, Ontario--(Newsfile Corp. - April 16, 2025) - Caprock Mining Corp. (CSE: CAPR) ("Caprock" or the "Company"), is pleased to announce details of a systematic exploration and resource expansion plan for its flagship Destiny gold property ("Desti